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ABSTRACT Hidradenitis suppurativa (Hs) is a chronic inflammatory 
dermatological disease with inflammatory mechanisms overlapping 
those of psoriasis, and both diseases have been associated with car-
diovascular risk factors i.e. smoking and metabolic syndrome. two 
studies have recently linked psoriasis with Atrial fibrillation (Af). Af is 
the most frequently occurring cardiac arrhythmia in the general pop-
ulation and is typically accompanied by increased heart rate. Both Af 
and heart rate are linked with inflammation. 
the aim of the study was to investigate a potential association be-
tween Hs and increased heart rate as well as Af.
We performed a comparative cross-sectional study using digital mea-
surements of heart rate and resting 12-lead electrocardiography (eCg) 
in combination with self-reported information when diagnosing Af.
Our study comprised 32 individuals with Hs from the hospital (the hos-
pital Hs group), 430 from the general population Hs group (the popu-
lation Hs group), and 20,780 controls. Age and sex adjusted analysis 
demonstrated a significantly higher heart rate in the Hs groups vs. 
controls (15% (range: 8-23%) higher for the hospital Hs group and 4% 
(2-5%) higher for the population Hs group). We found no association 
between Hs and Af (P=0.1670). 
KEY WORDS: heart rate, atrial fibrillation, arrhythmia, epidemiology, 
hidradenitis suppurativa (Hs), inflammation
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INTRODUCTION
 Hidradenitis suppurativa (Hs) is a chronic inflam-
matory dermatological disease presenting itself as 
painful nodules, tunnels, and subsequent scarring of 
the inverse regions i.e. axillar, inguinal, and anogenital 
areas(1). recent studies indicate a prevalence of 2.1% 
in the general population (2) and a rising incidence (3). 
Hs is associated with smoking as well as a substantial 
range of psychological and somatic comorbidities such 
as depression and the cluster of cardiovascular risk fac-
tors included in the metabolic syndrome i.e. diabetes, 
hypertension, dyslipidemia, and obesity (4-6).
 Atrial fibrillation (Af) is the most frequently occur-
ring cardiac arrhythmia with a prevalence of 0.4-1.0% 
of the general population (7), and is associated with 
increased risk of cardiovascular mortality and morbid-
ity i.e. stroke, heart failure, and myocardial infarction 
(8,9). in Af, the electrical impulses from the sinoatrial 
node in the atria are disrupted with a subsequent ir-
regular heart rhythm and often elevated heart rate (7). 
the pathogenesis is not yet fully understood; however, 
hypertension, diabetes, obesity, and smoking increase 
the risk of Af (8,10,11). Af and increased resting heart 
rate have however both been linked with inflamma-
tion. recently, studies reported the presence of inflam-
matory cells in the atria, raised inflammatory markers, 
and oxidative stress in patients with Af(12-20). 
 the inflammatory pathogenesis in Hs is not yet ful-
ly understood, but studies suggest involvement of il-
12/th1, il-23/th17 adaptive immune system pathways 
and tnf-alpha, as in the pathophysiology of psoriasis, 
but also the involvement of toll-like receptors, indi-
cating involvement of the innate immune system, i.e. 
macrophages and dendritic cells (21-25). interestingly, 
a recent large study reported increased risk of both Af 
and stroke in patients with psoriasis from the general 
population (26). in addition, Af was demonstrated in 
hypertensive patients with psoriasis (27), and a small 
study of 32 participants linked psoriasis to raised heart 
rate and increased frequency of supraventricular extra-
systoles(28). 
 Our objective was to investigate a potential asso-




 this study was accepted by the ethics committee 
of region Zealand (project number sJ-191, sJ-113, sJ-
114) in Denmark. Written informed consent was ob-
tained from all study participants.
Study design
 We performed a comparative cross-sectional study 
of the association of Hs (the exposure) and heart rate 
as well as atrial fibrillation (the outcomes). We inves-
tigated two different Hs groups: 1) A population HS 
group identified in a general population sample using 
a validated questionnaire(2), and 2) A hospital HS group 
identified at a Department of Dermatology by a der-
matologist.
The HS groups 
 The population HS group was identified in the Dan-
ish general suburban Population study (gesUs), which 
was a cross-sectional study conducted from January 
2010 to October 2013 investigating the adult Danish 
general suburban population in naestved Municipal-
ity (70 km south of Copenhagen)(29). All citizens aged 
30+ and a random selection of those aged 20-30 years 
were invited. All participants in gesUs answered the 
gesUs-questionnaire and also underwent a wide 
spectrum of health examinations. 
 the Hs diagnosis was established if participants self-
reported 1) the presence of boils within the previous 6 
months as well as 2) a minimum of 2 boils (in 5 possible 
locations: axillae, groin, genitals, inframammary areas, 
other – e.g. perianal region, neck, abdomen) in the ge-
sUs-questionnaire. this self-reported Hs diagnosis was 
previously validated showing a sensitivity of 90% and 
a specificity of 97% (2). the overall participation rate in 
gesUs was 49.3% (n=10,621 responded from the total 
n=21,557). Participants were more frequently women 
and had a higher median age. gesUs had sufficient 
power to study effects of rare and common exposures. 
further details about gesUs can be found in Bergholdt 
et al. (29).
 The hospital HS group was recruited from the out-
patient clinic at the Department of Dermatology at 
roskilde Hospital in Denmark (serving the region of 
Zealand which includes naestved). inclusion criteria 
were the World Health Organization’s international 
Classification of Diseases (iCD) code, edition 10 (iCD-
10) of Hs (l73.2) and undergoing either systemic (e.g. 
rifampicine/clindamycine, tetracycline, cyclosporine, 
or tnf-alpha inhibitor) or CO2-laser treatment for Hs 
indicating moderate to severe disease. the diagnosis 
of Hs was physician-verified. the participation rate for 
the invited hospital Hs subjects was 34%. the distribu-
tion of age and sex did not differ between hospital par-
ticipants and non-participants (data not shown).
 Both Hs groups were compared with a control 
group consisting of participants from gesUs without 
Hs.
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Heart rate and atrial fibrillation
 Heart rate was measured digitally (Blood Pressure 
Apparatus type A&D UA-787, A&D Medical, tokyo, Ja-
pan) after 5 minutes of rest in the hospital Hs group, 
the population Hs group, as well as the controls. in ad-
dition, all population based participants underwent a 
resting 12-lead electrocardiography (eCg) at 150 Hz 
(Mac-5500, ge Healthcare, Milwaukee, Wi). eCgs were 
coded according to the automatic eCg analysis pro-
gram (Marchette 12 sl revision e, ge Healthcare). Both 
heart rate and eCg measurements of all participants 
were standardized and performed by trained staff 
from gesUs.
 the diagnosis of atrial fibrillation was established if 
1) the participant self-reported non-specified medical 
treatment for Af (“Are you currently taking medicine 
for atrial fibrillation? (yes/no)) in the gesUs question-
naire; and/or 2) An automatic eCg code for atrial fibril-
lation or atrial flutter was given for the participant.
Statistical analyses
 for the continuous outcome (heart rate), the mean 
of each group as well as mean difference was calculat-
ed with a corresponding 95% Ci and P-value. the data 
was log-transformed before analyses in order to fit the 
statistical model, and is therefore reported as a ratio of 
Means (rM).  
 the categorical outcome (Af) was reported as Odds 
ratio (Or) with a corresponding 95% Ci and P-value.
 Unadjusted rM/Or was calculated. furthermore, we 
conducted three regression models (linear regression 
for the continuous outcome and logistic regression for 
the categorical outcome) adjusting for background 
factors and potential confounders: 1) age-sex-adjust-
ed; 2) age-sex-smoking adjusted; 3) age-sex-smoking-
BMi (obesity) / DM adjusted; 4) age-sex-smoking-anti-
coagulant medicine, left ventricular hypertrophy (lVH), 
artificial heart valves, and hypertension-adjusted.
 Additionally, we explored the influence of Hs sever-
ity by subgroup analysis of all Hs participants with se-
vere Hs and by regression models investigating a po-
tential association between the continuous outcome 
and the number of boils, as well as sartorius score. 
 the tests were two-sided with the significance level 









Age ((years) mean (range)) 42 (22-64) 48 (22-78) 56 (20-96)
Sex % (number) female vs. Male 78% vs. 22% 68% vs. 32% 54% vs. 46%













Ethnicity % (number) Caucasian 97% 97% 99% 





sartorius score (median (range))
    [lower quartile, upper quartile]
number of boils (median (range))





      [25-50]
12 (1-171)
















     Mean (min-max) 31.3(21.5-46.5) 28.85(17.6-47.8) 26.7(14.23-57.5)
Diabetes Mellitus (%) 12.5% 8.3% 6.1%
Self-reported anticoagulent medicine 9.4% 7.2% 10.2%
Left Ventricular Hypertrophia in ECG 0% 0.7% 1.95%
Self-reported artificial heart valves 0% 0.4% 0.4%
Hypertension 
(self-reported antihypertensive 
medicine and measured ≥140/90)
56.3% 49.1% 60.8%
Table1. Background factors and characteristics for the hospital hidradenitis suppurativa (Hs) group,  
population Hs group, and controls
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HS Severity
 Hs severity was explored with 3 different approach-
es: 1) A non-validated scoring system inspired by but 
not entirely equivalent to the Hurley score (30) based 
on self-reported information from the gesUs-question-
naire (Mild Hs: minimum 2 boils and no subsequent 
scarring; moderate Hs: minimum 2 boils and subse-
quent scarring; severe Hs: minimum 2 boils in minimum 
2 locations and subsequent scarring); 2) number of self-
reported boils; and 3) sartorius score based on physical 
examination (30) (the hospital Hs group).
RESULTS
 Our study comprised a total of 32 individuals 
in the hospital Hs group, 430 in the population Hs 
group, and 20,780 controls. the background factors 
and characteristics revealed that the Hs groups were 
predominately younger, female, and smokers 
Heart rate
 Unadjusted data found a higher heart rate for the 
Hs groups when compared with controls (table 2). Age 







































Heart Rate (Beats per minute)
i. Unadjusted rM (95% Ci)
ii. Age-sex adjusted rM (95% Ci)
iii. Age-sex-smoking adjusted rM (95%Ci)
iV. Age-sex-smoking-BMi adjusted rM (95%Ci)






















i. Unadjusted Or (95% Ci)
ii. Age-sex adjusted Or (95% Ci)
iii. Age-sex-smoking adjusted Or (95%Ci)
iV. Age-sex-smoking-anticoagulant medicine, lVH, artificial  











Missing values:  12 (heart rate, controls)
the diagnose atrial fibrillation/flutter (Af) was based on 1) self-reported medical treatment for Af and/or 2) An eCg code 
for Af (either atrial fibrillation with normal/rapid frequency, atrial flutter either 1:1/1:2/1:3/1:4/1:5/1:>5, atrial flutter with 
AV-block, atrial fibrillation with premature aberrant complexes, atrial fibrillation with concurrent nodal pacemaker, atrial 
fibrillation with slow ventricular response, or paroxysmal atrial flutter)
Table 3. Unadjusted and adjusted ratio of Means (rM) and Odds ratio (Or)
rM: ratio of Means. Or: Odds ratio. lVH: left Ventricular Hypertrophia. BMi: Body Mass index. DM: Diabetes Mellitus
95% Ci: 95% confidence interval. *: statistically significant at a 0.05 level
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Heart Rate (Beats per minute)
i. Unadjusted rM (95% Ci)
ii. Age-sex adjusted rM (95% Ci)














i. Unadjusted Or (95% Ci)
ii. Age-sex adjusted Or (95% Ci)
iii. Age-sex-smoking adjusted Or (95%Ci)
iV. Age-sex-smoking-anticoagulant medicine, lVH, artificial      











rMhos of 1.15 (Ci 95% 1.08-1.23) and rMpop of 1.04 
(1.02-1.05) for the hospital and population Hs groups 
when compared with controls, respectively (table 
3). the hospital-based results remained robust after 
further adjusting for potential confounders: smok-
ing, obesity and DM (table 3). the population-based 
results remained robust after adjusting for smoking; 
however, they became statistically insignificant when 
further adjusting for BMi or DM (table 3).
Atrial fibrillation / flutter (AF)
 Both crude data and all adjusted analysis revealed 
non-significant Orpop for the population Hs group vs. 
controls (table 3). no patients in the hospital Hs group 
reported medical treatment for Af, and no eCg data 
was available for the hospital Hs group.
HS severity
 subgroup analysis of severe Hs groups demon-
strated slightly higher rMs of heart rate compared 
with the above, and the results remained non-signifi-
cant with regard to Af (table 4). regression analysis re-
vealed non-significant association between heart rate 
and number of boils (P=0.2198), heart rate and sarto-
rius score (P=0.4392) as well as Af and number of boils 
(0.6672). 
DISCUSSION
 this current novel study demonstrated a higher 
heart rate in Hs groups compared with controls, but, in 
contrast to our hypothesis, no association between Hs 
and Af was found. 
 Heart rate is highly influenced by the central ner-
vous system as it is mainly controlled by the autonom-
ic nervous system, i.e. sympathetic/parasympathetic 
activity. Heart rate furthermore varies according to the 
body’s physical needs, medical conditions e.g. hyper-
thyroidism, psychological state e.g. anxiety/stress, and 
drugs (31,32). 
 Accumulating evidence indicated a connection be-
tween inflammation and heart rate. Higher heart rate 
along with reduced heart rate variability was associat-
ed with subclinical inflammation in otherwise healthy 
people when using C-reactive protein as an inflamma-
tory marker (33). tnf-alpha, which has been shown to 
be elevated in Hs, has been found to exhibit toxic ef-
fects on cardiomyocytes (34,35), and other inflamma-
tory markers such as thromboxane A2 and prostaglan-
din f2alpha have been found to mediate inflammatory 
tachycardia (heart rate above 100 beat/minute) (36). 
furthermore, a study proposed that inflammatory re-
actions and oxidative stress may be involved in tachy-
cardia-induced heart failure (37). endotoxin injection 
mimicking acute inflammation was observed to in-
duce tachycardia and raised systolic blood pressure 
in mice and humans (38). Although heart rates were 
not high enough to be classified as tachycardia, Hs 
patients exhibited a higher median heart rate com-
pared with healthy controls (crude median 83 beats/
minute for hospital Hs group, 74.42 beats/minute for 
population Hs group vs. 71 beats/minute for controls). 
set side by side with psoriasis, which is as mentioned 
also an inflammatory skin disease involving th1 cells, a 
significantly higher mean heart rate of 88 beats/min-
ute for patients with psoriasis vs. 73 beats/minute for 
controls was noted in a previous study (28). We could 
not demonstrate a convincing dose-response relation-
ship when exploring Hs severity, suggesting no causal 
Table 4. subgroup analysis of severe hidradenitis suppurativa (Hs)
Miller et al. Acta Dermatovenerol Croat
PV severity scores indicating ent damage  2018;26(4):289-296
ACTA DERMATOVENEROLOGICA CROATICA 293
294
relationship. However, the measurement of Hs sever-
ity may not have been optimal, and the small hospital 
sample may result in lack of power. 
 the clinical significance of the findings in this study 
is unknown. looking at general health, high resting 
heart rate has been found to be associated with higher 
age, low physical fitness level, hyperthyroidism, obe-
sity, hypertension, diabetes, metabolic syndrome, 
psychological stress (involving the autonomic nerve 
system), higher mortality, and reduced longevity, sug-
gesting several possible co-factors in patients with 
Hs (31,39-43). On an experimental basis, reduction of 
heart rate in mice by 14% has been found to increase 
longevity by 6.2% (44). notably, hyperthyroidism has 
been linked with Hs (43,45). When adjusting for the 
most prominent co-factors i.e. obesity (BMi) and dia-
betes, the association between higher heart rate and 
hidradenitis was reduced but remained significant for 
the hospital-based Hs group but not for the popula-
tion-based Hs group. thus, obesity and diabetes may 
act as partial confounders. 
 We found no association between Af and Hs. Our 
hypothesis predicted an association based on immu-
nological similarities with psoriasis which has recently 
been associated with Af in a large population-based 
cohort as well as in a cohort of hypertensive patients 
with psoriasis (26,27). However, one small study using 
the Holter method analyzed by Cardioscan software 
found no complex arrhythmia but only single supra-
ventricular extrasystoles significantly more frequently 
in patients with psoriasis than controls(28). 
 rejection of the a priori hypothesis often poses a 
challenge. non-significant results contain an equal 
amount of scientific information; however, potential 
interpretations appear less forthright as absence of 
evidence is not the same as evidence of absence (46). 
Potential explanations may be postulated regarding 
the link between Af and psoriasis, but not Hs. the in-
flammatory profiles of psoriasis and Hs are not similar 
but do overlap. the relation between inflammation 
and Af may be exhibited by pro-arrhythmic effects of 
cytokines like tnf-alpha (47,48). tissue levels of tnf-
alpha are however higher in Hs than in psoriasis, and 
other mechanisms may therefore be of interest (25). 
 Hypertension predisposes Af. two of the studies 
on the link between the individual Mets-components 
and Hs suggest that the weakest association is that of 
hypertension. A study we previously conducted on the 
same group of gesUs-patients found a non-significant 
association to hypertension (42). sabat et al. found that 
the average systolic and diastolic blood pressure was 
significantly higher in patients with Hs vs. controls, but 
the frequency of actual hypertension was not higher 
(49). thus, the lack of association between Hs and Af 
when compared with the existing association between 
psoriasis and Af may be attributed to the fact that the 
association between psoriasis and hypertension is 
stronger than that of Hs and hypertension. However, 
adjustments for higher average systolic and diastolic 
blood preasure did not change the results. further-
more, our control group had 2.38% patients with a di-
agnosis of Af (table 2), which is high compared with 
the general Af prevalence of 0.4-1% reported in previ-
ous studies (7). in fact, the population Hs group had a 
higher percentage of patients with Af compared with 
the general Af prevalence (1.63% vs 0.4-1%) (table 2).
 finally, one explanation for these results could sim-
ply be the methodological differences between the 
psoriasis studies and the current study. 
 One of the considerable shortcomings of the cur-
rent study is the method of diagnosing Af, which was 
based on eCg automatic coding at a single point in 
time. On the other hand, the Af diagnosis also includes 
self-reported medical treatment of Af. the two previ-
ously conducted studies on the possible association of 
psoriasis and Af may have benefitted from more opti-
mized methods of diagnosing Af, namely according to 
Minnesota coding or iCD-10 codes from a previously 
validated national Patients registry, yielding 99% of 
confirmed Af diagnoses (26,27). further notable limi-
tations are the potential sources of selection bias pos-
sibly hampering the generalizability: the population is 
suburban, Caucasian, and the low participation rate of 
the hospital Hs group may represent only the healthi-
est Hs patients. furthermore, we did not have eCg data 
on the hospital group.
 the primary advantages of our study are the large 
and broad inclusion, i.e. including Hs patients from 
both a hospital environment as well as the general 
population and mild to severe Hs, yielding high pow-
er as well as reduced selection bias and thus aiding 
generalization. Possible misclassification bias, e.g. un 
/ misdiagnosed Hs patients, was minimized by using 
previously validated self-reported questions referring 
to symptoms (i.e. boils) rather than the actual diagno-
sis (i.e. “do you suffer from Hs?”) (2). the diagnosis for 
hospital Hs was physician-verified. finally, potential 
confounders were explored.
 As predicted by our hypothesis, Hs was associated 
with a higher heart rate compared with controls. How-
ever, Hs was not associated with Af. 
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